Sunny
Sunny is an MD candidate at Harvard Medical School. Previously, she spent seven years researching neurodegenerative diseases. Notably, she was a part of a group studying cell replacement therapy for Parkinson’s disease which, in 2021, entered a Phase I clinical trial for patients with advanced Parkinson's disease
Hana
Hana double-majored in Sociology and Dance at Columbia University, where she graduated with departmental honors and Phi Beta Kappa. She also holds a Doctor of Physical Therapy degree from Hunter College, and she practices as a physical therapist.
Elizabeth
Elizabeth is an MD/PhD student at NYU School of Medicine's Medical Scientist Training Program. She holds a BA in Biology with a minor in English from Hunter College.